Aldevron News: Events

Aldevron's Antibody Discovery Team Participating at PEGS

Patricia Odermatt, Senior B-cell Scientist with Aldevron’s Antibody business unit, will be presenting at the  PEGS Boston Summit at 11:30 EDT on Monday, August 31. Her presentation,  Rapid Human Antibody Discovery Utilizing Ligand’s OmniRat® Platform and Berkeley Lights’ Beacon® Instrument will show how three antibody discovery platforms are being used together in developing fully human antibodies against SARS-CoV-2 targets. Patricia will be available at the Aldevron digital booth for additional discussions throughout PEGS. The presentation is only available to those registered for PEGS, which you can find here. However, anyone can connect with our Antibody team at any time through our contact form.
Read More

Aldevron Participates in Panel Discussion at Rejuvenation Biotechnology 2016

Dr. James Brown, Aldevron’s Vice President of Corporate Development, will be speaking on a panel at the Rejuvenation Biotechnology 2016 Conference at the Buck Institute for Research on Aging in Novato, California.

The conference takes place August 16-17 and the panel titled “As Paths To Clinic Are Expedited, The Distinction Between Development And Manufacturing Is Becoming Increasingly Blurred” will be on August 17 from 10:15 AM to Noon PST.

Dr. Brown will be joined by fellow panelists Sean Kevlahan, Chief Executive Officer and Co-founder of Quad Technologies, and Alan Moore, Vice President and Commercial Chief for Biologics and Advanced Therapies of Wuxi AppTec. The panel will be moderated by Eric Roos, Strategic Alliances Leader, Cell Therapy, Thermo Fisher Scientific.

Read More